Leptin and tumor growth in rats

Area of Science:

• Oncology
• Endocrinology
• Metabolism

Background:

• Tumor-induced anorexia is a complex condition affecting cancer patients.
• Leptin, a hormone produced by adipose tissue, regulates appetite and energy balance.
• The role of leptin in cancer-related appetite loss requires further investigation.

Purpose of the Study:

• To investigate the role of leptin in tumor-induced anorexia in two distinct experimental cancer models.
• To determine if changes in leptin levels precede or coincide with the onset of anorexia in tumor-bearing animals.

Main Methods:

• Utilized two tumor models: Yoshida AH-130 ascites hepatoma in rats and Lewis lung carcinoma in mice.
• Measured circulating leptin levels and adipose tissue leptin mRNA expression at various time points post-tumor inoculation.
• Employed pair-fed control groups to differentiate tumor effects from reduced food intake.

Main Results:

• In both tumor models, circulating leptin levels and adipose leptin mRNA expression were reduced early after tumor inoculation, even before anorexia was evident.
• These reductions in leptin mirrored changes observed in pair-fed control animals, suggesting a link to reduced food intake rather than the tumor itself.
• Observed decreased leptin levels in all tumor-bearing groups compared to controls.

Conclusions:

• Experimental cancer-induced anorexia does not appear to be directly related to changes in leptin levels.
• Reduced leptin expression in tumor-bearing animals may be a consequence of decreased food intake (fasting response) rather than a direct effect of the tumor.
• Further research is needed to elucidate the precise mechanisms underlying tumor-induced anorexia.